Detail of the clinical trial
| Title of the trial | A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 versus Treatment Choice (TC) in Adults with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy |
|---|---|
| EudraCT number | 2014-001233-89 |
| Protocol number | SGI-110-04 |
| Sponsor | Astex Pharmaceuticals, Inc., 4420 Rosewood Drive Ste 200, Pleasanton, CA 94588, United States of America |
| Indications | Hemato-oncology |
| Diagnosis | Myeloid leukemia |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2015 |
| Date of approval by Institute (SÚKL) | 23.4.2015 |
| Date of approval by EC | 13.5.2015 |
| Date of initiation CT in ČR | 4.8.2015 |
| Date of ending CT in ČR | 28.8.2018(30.5.2018) |
| Notice | |
| Sites |
Všeobecná fakultní nemocnice ,I.interní klinika ? klinika hematologie,U nemocnice 2,128 08 Praha 2 Fakultní nemocnice Královské Vinohrady ,Interní hematologická klinika ,Šrobárova 1150/50,100 34 Praha 10 Fakultní nemocnice Brno,Interní hematologická a onkologická klinika,Jihlavská 20,625 00 Brno |
cz